| Application number | Title of the application | Filing Date | Status |
|---|
| 09/241224 | PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IKAPPAB-ALPHA | Jan 31, 1999 | Abandoned |
| 09/202997 | PROCESS FOR THE PREPARATION OF PENAM AND PENEM DERIVATIVES | Jan 28, 1999 | Abandoned |
Array
(
[id] => 4306847
[patent_doc_number] => 06187922
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-02-13
[patent_title] => 'Process for the preparation of purine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/238777
[patent_app_country] => US
[patent_app_date] => 1999-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1496
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/187/06187922.pdf
[firstpage_image] =>[orig_patent_app_number] => 238777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/238777 | Process for the preparation of purine derivatives | Jan 26, 1999 | Issued |
Array
(
[id] => 4411692
[patent_doc_number] => 06310205
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Hypoxathine compounds'
[patent_app_type] => 1
[patent_app_number] => 9/237638
[patent_app_country] => US
[patent_app_date] => 1999-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5406
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/310/06310205.pdf
[firstpage_image] =>[orig_patent_app_number] => 237638
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/237638 | Hypoxathine compounds | Jan 25, 1999 | Issued |
| 09/236013 | PROCESS FOR THE PRODUCTION OF CLAVULANIC ACID SALTS | Jan 21, 1999 | Abandoned |
Array
(
[id] => 4194780
[patent_doc_number] => 06043356
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Process for preparing .beta.-lactam compound'
[patent_app_type] => 1
[patent_app_number] => 9/233426
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8319
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043356.pdf
[firstpage_image] =>[orig_patent_app_number] => 233426
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233426 | Process for preparing .beta.-lactam compound | Jan 19, 1999 | Issued |
Array
(
[id] => 4320442
[patent_doc_number] => 06248746
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-19
[patent_title] => '3-(arylalkyl) xanthines'
[patent_app_type] => 1
[patent_app_number] => 9/227057
[patent_app_country] => US
[patent_app_date] => 1999-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6558
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/248/06248746.pdf
[firstpage_image] =>[orig_patent_app_number] => 227057
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/227057 | 3-(arylalkyl) xanthines | Jan 6, 1999 | Issued |
Array
(
[id] => 4362905
[patent_doc_number] => 06255479
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-03
[patent_title] => 'Process for the preparation of .alpha.-oxolactams'
[patent_app_type] => 1
[patent_app_number] => 9/222519
[patent_app_country] => US
[patent_app_date] => 1998-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4451
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/255/06255479.pdf
[firstpage_image] =>[orig_patent_app_number] => 222519
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/222519 | Process for the preparation of .alpha.-oxolactams | Dec 28, 1998 | Issued |
Array
(
[id] => 710804
[patent_doc_number] => RE039112
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2006-05-30
[patent_title] => 'Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes'
[patent_app_type] => reissue
[patent_app_number] => 11/057854
[patent_app_country] => US
[patent_app_date] => 1998-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39685
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/039/RE039112.pdf
[firstpage_image] =>[orig_patent_app_number] => 11057854
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/057854 | Purine derivatives and adenosine A2 receptor antagonists serving as preventives/remedies for diabetes | Dec 23, 1998 | Issued |
Array
(
[id] => 4098907
[patent_doc_number] => 06096883
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-08-01
[patent_title] => '3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones'
[patent_app_type] => 1
[patent_app_number] => 9/210921
[patent_app_country] => US
[patent_app_date] => 1998-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6598
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/096/06096883.pdf
[firstpage_image] =>[orig_patent_app_number] => 210921
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210921 | 3-hydroxy gamma-lactone based enantioselective synthesis of azetidinones | Dec 13, 1998 | Issued |
| 09/202330 | PROCESS FOR THE PREPARATION OF CARBAPENEM DERIVATIVES AND INTERMEDIATES THEREOF | Dec 10, 1998 | Abandoned |
Array
(
[id] => 4410406
[patent_doc_number] => 06228859
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Purine derivatives having phosphodiesterase IV inhibition activity'
[patent_app_type] => 1
[patent_app_number] => 9/210556
[patent_app_country] => US
[patent_app_date] => 1998-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9645
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228859.pdf
[firstpage_image] =>[orig_patent_app_number] => 210556
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210556 | Purine derivatives having phosphodiesterase IV inhibition activity | Dec 10, 1998 | Issued |
Array
(
[id] => 4291276
[patent_doc_number] => 06211367
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity'
[patent_app_type] => 1
[patent_app_number] => 9/210557
[patent_app_country] => US
[patent_app_date] => 1998-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11658
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/211/06211367.pdf
[firstpage_image] =>[orig_patent_app_number] => 210557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/210557 | Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity | Dec 10, 1998 | Issued |
Array
(
[id] => 4222302
[patent_doc_number] => 06040447
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-21
[patent_title] => 'Purine compounds having PDE IV inhibitory activity and methods of synthesis'
[patent_app_type] => 1
[patent_app_number] => 9/209922
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4175
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 392
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/040/06040447.pdf
[firstpage_image] =>[orig_patent_app_number] => 209922
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209922 | Purine compounds having PDE IV inhibitory activity and methods of synthesis | Dec 9, 1998 | Issued |
Array
(
[id] => 4181511
[patent_doc_number] => 06037470
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-14
[patent_title] => 'Purine compounds having PDE IV inhibitory activity and methods of synthesis'
[patent_app_type] => 1
[patent_app_number] => 9/209658
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3679
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 423
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/037/06037470.pdf
[firstpage_image] =>[orig_patent_app_number] => 209658
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209658 | Purine compounds having PDE IV inhibitory activity and methods of synthesis | Dec 9, 1998 | Issued |
Array
(
[id] => 4187252
[patent_doc_number] => 06093712
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-25
[patent_title] => 'Cephalosporin derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/209122
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19965
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/093/06093712.pdf
[firstpage_image] =>[orig_patent_app_number] => 209122
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209122 | Cephalosporin derivatives | Dec 9, 1998 | Issued |
Array
(
[id] => 4111320
[patent_doc_number] => 06057445
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-02
[patent_title] => 'Purine compounds having PDE IV inhibitory activity and methods of synthesis'
[patent_app_type] => 1
[patent_app_number] => 9/209664
[patent_app_country] => US
[patent_app_date] => 1998-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4953
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 342
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/057/06057445.pdf
[firstpage_image] =>[orig_patent_app_number] => 209664
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/209664 | Purine compounds having PDE IV inhibitory activity and methods of synthesis | Dec 9, 1998 | Issued |
| 09/206931 | PROCESS FOR THE SYNTHESIS OF AZETIDINONES | Dec 6, 1998 | Abandoned |
| 09/205254 | 2-(PYRAZOL-3-YL)CARBAPENEM DERIVATIVES | Dec 3, 1998 | Abandoned |
| 09/117823 | FAMCICLOVIR MONOHYDRATE | Dec 1, 1998 | Abandoned |
